Blood cancer treatment: How multiple myeloma became nearly curable

With treatment advances over the last few years, and particularly in recent months, multiple myeloma has become treatable and may soon be curable.

Multiple myeloma survivor: Having additional treatment options gives me hope

Multiple myeloma survivor Beth Norris has been on some form of multiple myeloma treatment for the past five years. Today, she shows no evidence of disease, thanks to a CAR T cell therapy clinical t...

Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. - Journal of Clinical Oncology

Abstract ; Purpose : We present a phase I/II first-in-human trial evaluating the safety and efficacy of 50 mg and 200 mg doses of linvoseltamab, a B-cell maturation antigen × CD3 bispecific antibody in relapsed/refractory multiple myeloma (RRMM). Methods : Phase II eligible patients had RRMM that either progressed on/after ≥three lines of therapy including a proteasome inhibitor (PI), an immunomodulatory drug (IMiD), and an anti-CD38 antibody or was triple-class (PI/IMiD/anti-CD38) refractor...

CAR T-Cell Therapy for Multiple Myeloma: What to Expect

CAR T-cell therapy for multiple myeloma uses genetically engineered T cells to fight cancer. Learn about the preparation, procedure, potential side effects, and more.

Multiple Myeloma Treatments | Massive Bio

Multiple myeloma treatments have advanced considerably, providing patients with a range of options to manage this type of blood cancer.

Treatment Sequencing Strategies for Patients with Relapsed/ Refractory Multiple Myeloma - Cancer Network

EP: 1.Current Landscape of Relapsed/ Refractory Multiple Myeloma ; EP: 2.Management of Relapsed/Refractory Multiple Myeloma with Bispecifics: MonumenTAL-2, MajesTEC-1, and MagnetisMM-3 trials ; EP: 3.Bispecifics in Relapsed/ Refractory Multiple Myeloma: Combination Strategies, Stepping Up, and Treatment Dose Considerations

Multiple myeloma

Multiple myeloma Other names Plasma cell myeloma, myelomatosis, Kahler's disease, myeloma [1]... eligible for treatment with myeloma drugs earlier.[22] Bone pain [edit] Illustration showing...

Has Your Multiple Myeloma Treatment Stopped Working?

Signs Your Treatment Stopped Working · When Early Treatments Stop Working · Late-Stage Treatment Options

MULTIPLE MYELOMA - Targeted Oncology

FDA Grants Orphan Drug Designation to LBL-034 in Multiple Myeloma ; Treatment Delays in Multiple Myeloma Highlight Racial and Age Disparities ; CAR T and CRS Adverse Events Considered in Relapsed Multiple Myeloma

Multiple Myeloma | Multiple Myeloma Information | American Cancer Society

Whether you (or a loved one) are worried about developing multiple myeloma, have just been diagnosed, are going through treatment, or are trying to stay well after treatment, this detailed guide ca...